To test this hypothesis, DNA methylation of TGFβ regulators and effectors was analyzed in vitro in HCC cells, and further evaluated on resected human HCC samples to determine the clinical relevance of DNA methylation. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.